OBJECTIVES: The aim of this study was to identify new prognostic factors in metastatic renal cell carcinoma (RCC) based on the analysis of precisely defined metastatic tissue. METHODS: Expression profiling was done on 26 snap-frozen samples of clear-cell RCC metastases with complete follow-up (up to 116 months) using laser microdissection and oligonucleotide microarrays (Affymetrix). A prognosis-associated gene signature was determined using the semi-supervised principal components analysis method. Validation was performed with quantitative RT-PCR on samples of normal renal tissue (n = 6), RCC primary tumor (n = 57), and RCC metastases (n = 59). Immunohistochemistry (IHC) was done to localize HNF-1B. RESULTS: Analysis of expression data revealed a three-gene signature consisting of HNF-1B, KIAA1919, and SYDE1, which discriminated well between 2 prognosis groups (P < .05), independently of the TNMG classification. Expression of HNF-1B was analyzed in detail. HNF-1B mRNA expression correlated with malignant transformation and progression (normal renal tissue > primary tumor > metastasis; P < .0001). There was a significant correlation between high HNF-1B mRNA expression in primary tumor and better prognosis (P < .05). IHC showed a specific nuclear HNF-1B staining confined to the tumor cells of the primary tumors and of the metastases. CONCLUSIONS: The level of HNF-1B mRNA expression significantly decreases with tumor progression, and patients with high HNF-1B mRNA levels have a significantly better prognosis. HNF-1B might be a useful prognostic factor for metastatic RCC and also a potential therapeutic target in the future. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVES: The aim of this study was to identify new prognostic factors in metastatic renal cell carcinoma (RCC) based on the analysis of precisely defined metastatic tissue. METHODS: Expression profiling was done on 26 snap-frozen samples of clear-cell RCC metastases with complete follow-up (up to 116 months) using laser microdissection and oligonucleotide microarrays (Affymetrix). A prognosis-associated gene signature was determined using the semi-supervised principal components analysis method. Validation was performed with quantitative RT-PCR on samples of normal renal tissue (n = 6), RCC primary tumor (n = 57), and RCC metastases (n = 59). Immunohistochemistry (IHC) was done to localize HNF-1B. RESULTS: Analysis of expression data revealed a three-gene signature consisting of HNF-1B, KIAA1919, and SYDE1, which discriminated well between 2 prognosis groups (P < .05), independently of the TNMG classification. Expression of HNF-1B was analyzed in detail. HNF-1B mRNA expression correlated with malignant transformation and progression (normal renal tissue > primary tumor > metastasis; P < .0001). There was a significant correlation between high HNF-1B mRNA expression in primary tumor and better prognosis (P < .05). IHC showed a specific nuclear HNF-1B staining confined to the tumor cells of the primary tumors and of the metastases. CONCLUSIONS: The level of HNF-1B mRNA expression significantly decreases with tumor progression, and patients with high HNF-1B mRNA levels have a significantly better prognosis. HNF-1B might be a useful prognostic factor for metastatic RCC and also a potential therapeutic target in the future. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Sonja I Berndt; Joshua Sampson; Meredith Yeager; Kevin B Jacobs; Zhaoming Wang; Amy Hutchinson; Charles Chung; Nick Orr; Sholom Wacholder; Nilanjan Chatterjee; Kai Yu; Peter Kraft; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Christopher Haiman; Brian Henderson; Laurence Kolonel; Loic Le Marchand; Afshan Siddiq; Elio Riboli; Ruth C Travis; Rudolf Kaaks; William Isaacs; Sarah Isaacs; Kathleen E Wiley; Henrik Gronberg; Fredrik Wiklund; Pär Stattin; Jianfeng Xu; S Lilly Zheng; Jielin Sun; Lars J Vatten; Kristian Hveem; Inger Njølstad; Daniela S Gerhard; Margaret Tucker; Richard B Hayes; Robert N Hoover; Joseph F Fraumeni; David J Hunter; Gilles Thomas; Stephen J Chanock Journal: Hum Mol Genet Date: 2011-05-16 Impact factor: 6.150
Authors: Mianen Sun; Pan Tong; Wen Kong; Baijun Dong; Yiran Huang; In Young Park; Lijun Zhou; Xian-De Liu; Zhiyong Ding; Xuesong Zhang; Shanshan Bai; Peter German; Reid Powell; Quan Wang; Xuefei Tong; Nizar M Tannir; Surena F Matin; W Kimryn Rathmell; Gregory N Fuller; Ian E McCutcheon; Cheryl L Walker; Jing Wang; Eric Jonasch Journal: Cancer Res Date: 2017-08-14 Impact factor: 12.701
Authors: Kristýna Němejcová; Ivana Tichá; Petra Kleiblová; Michaela Bártů; David Cibula; Kateřina Jirsová; Pavel Dundr Journal: Pathol Oncol Res Date: 2015-12-19 Impact factor: 3.201
Authors: Jodie N Painter; Tracy A O'Mara; Jyotsna Batra; Timothy Cheng; Felicity A Lose; Joe Dennis; Kyriaki Michailidou; Jonathan P Tyrer; Shahana Ahmed; Kaltin Ferguson; Catherine S Healey; Susanne Kaufmann; Kristine M Hillman; Carina Walpole; Leire Moya; Pamela Pollock; Angela Jones; Kimberley Howarth; Lynn Martin; Maggie Gorman; Shirley Hodgson; Ma Magdalena Echeverry De Polanco; Monica Sans; Angel Carracedo; Sergi Castellvi-Bel; Augusto Rojas-Martinez; Erika Santos; Manuel R Teixeira; Luis Carvajal-Carmona; Xiao-Ou Shu; Jirong Long; Wei Zheng; Yong-Bing Xiang; Grant W Montgomery; Penelope M Webb; Rodney J Scott; Mark McEvoy; John Attia; Elizabeth Holliday; Nicholas G Martin; Dale R Nyholt; Anjali K Henders; Peter A Fasching; Alexander Hein; Matthias W Beckmann; Stefan P Renner; Thilo Dörk; Peter Hillemanns; Matthias Dürst; Ingo Runnebaum; Diether Lambrechts; Lieve Coenegrachts; Stefanie Schrauwen; Frederic Amant; Boris Winterhoff; Sean C Dowdy; Ellen L Goode; Attila Teoman; Helga B Salvesen; Jone Trovik; Tormund S Njolstad; Henrica M J Werner; Katie Ashton; Tony Proietto; Geoffrey Otton; Gerasimos Tzortzatos; Miriam Mints; Emma Tham; Per Hall; Kamila Czene; Jianjun Liu; Jingmei Li; John L Hopper; Melissa C Southey; Arif B Ekici; Matthias Ruebner; Nicola Johnson; Julian Peto; Barbara Burwinkel; Frederik Marme; Hermann Brenner; Aida K Dieffenbach; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jeroen Depreeuw; Matthieu Moisse; Jenny Chang-Claude; Anja Rudolph; Fergus J Couch; Janet E Olson; Graham G Giles; Fiona Bruinsma; Julie M Cunningham; Brooke L Fridley; Anne-Lise Børresen-Dale; Vessela N Kristensen; Angela Cox; Anthony J Swerdlow; Nicholas Orr; Manjeet K Bolla; Qin Wang; Rachel Palmieri Weber; Zhihua Chen; Mitul Shah; Juliet D French; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Douglas F Easton; Stacey L Edwards; Deborah J Thompson; Amanda B Spurdle Journal: Hum Mol Genet Date: 2014-11-06 Impact factor: 6.150